Unifine Pentips Plus, hypodermic needle - Product Usage: Pen needles with built in pen needle rem...

FDA Device Recall #Z-2078-2021 — Class II — May 26, 2021

Recall Summary

Recall Number Z-2078-2021
Classification Class II — Moderate risk
Date Initiated May 26, 2021
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Owen Mumford USA, Inc.
Location Marietta, GA
Product Type Devices
Quantity 2,593 cartons of 100 ea.

Product Description

Unifine Pentips Plus, hypodermic needle - Product Usage: Pen needles with built in pen needle remover.

Reason for Recall

Mixed Up. Two (2) cases of Unifine Pentips Plus 4mm pen needles have been mixed into a packed configuration of Unifine Pentips Plus 8mm pen needles.

Distribution Pattern

US Nationwide distribution in the states of AL, AZ, CA, CO, FL, GA, HI, IA, IL, MA, MI, MN, MO, MS, NC, NH, NJ, NY, OH, OK, PA, TN, TX, UT, VA, VT, WA, and WV.

Lot / Code Information

Lot numbers: 20V4001.Z3999, Lot 20V4001.Z4019 and 20V4001.Z411

Other Recalls from Owen Mumford USA, Inc.

Recall # Classification Product Date
Z-0263-2020 Class II Autoject EI, REF AJ1310 Jul 17, 2019
Z-0264-2020 Class II Petfine Auto Injector, REF 3310VET Jul 17, 2019
Z-0381-2018 Class II Unifine Pentips 5mm x 31G pen needles, packaged... Nov 6, 2017
Z-0382-2018 Class II Unifine Pentips 5mm x 31G pen needles, packaged... Nov 6, 2017
Z-2082-2015 Class II Autopen Classic Automatic insulin delivery pen,... Dec 11, 2014

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.